Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
COLL
#1925
Collegium Pharmaceutical, Inc. Common Stock
41.670
0
-5.37%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-5.37%
Aylık değişim
-7.99%
6 aylık değişim
+18.58%
Yıllık değişim
+18.58%
Önceki kapanış
44.035
0
Open
41.670
0
Bid
Ask
Low
41.670
0
High
41.670
0
Hacim
114
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
COLL
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
34.76 M
33.38 M
34.07 M
31.96 M
31.49 M
31.75 M
—
Valuation ratios
Enterprise value
522.05 M
437.07 M
629.6 M
759.16 M
831.5 M
1.24 B
3.87 B
Price to earnings ratio
26.36
10.04
-31.86
24.21
15.4
26.76
101.4
Price to sales ratio
2.27
2.77
1.72
2.3
1.83
—
—
Price to cash flow ratio
7.49
7.4
6.42
4.75
5.65
5.58
21.35
Price to book ratio
3.78
3.78
4.09
6.68
5.06
6.09
9.9
Enterprise value to EBITDA ratio
2.79
2.78
14.22
4.27
4.68
—
—
Profitability ratios
Return on assets %
0.04
0.1
0.02
0.04
0.04
0.04
0.04
Return on equity %
0.14
0.35
0.13
0.25
0.3
0.21
0.23
Return on invested capital %
55.7
-250.47
13.05
39.22
36.25
33.1
34.17
Gross margin %
58.01
54.4
45.15
57.55
59.76
59.35
236.59
Operating margin %
18.14
6.37
7.18
29.46
26.91
23.01
90.1
EBITDA margin %
60.46
56.75
9.55
31.38
28.15
80.95
316.67
Net margin %
8.63
25.83
5.39
8.5
10.96
8.05
31.04
Liquidity ratios
Quick ratio
1.1
1.07
0.86
1.1
0.88
1.48
4.86
Current ratio
1.16
1.13
0.97
1.17
0.95
1.57
5.19
Inventory turnover
10.31
7.65
7.96
6.1
7.49
8.3
8.38
Asset turnover
0.65
0.41
0.5
0.49
0.45
0.47
0.48
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.33
0.29
0.46
0.42
0.47
0.49
1.9
Long term debt to total equity ratio
1.13
0.99
2.76
2.48
3.44
2.68
11.95
Per share metrics
Operating cash flow per share
2.67
2.52
3.67
6.57
5.07
8.29
8.6
EBIT per share
1.6
0.43
0.98
4
4.2
4.52
4.65
EBITDA per share
5.33
3.83
1.31
4.26
4.4
15.92
16.31
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.95
4.54
5.13
9.26
6.36
13.65
41.8
Net current asset value per share
7.91
7.69
12.41
12.86
11.93
17.42
62.94
Tangible book value per share
-4.26
-1.6
-14.97
-8.62
-20.41
-12.94
-68.66
Working capital per share
1.09
0.88
-0.41
1.91
-0.67
6.33
13.76
Book value per share
5.29
4.94
5.76
4.68
5.66
7.6
27.58
Haberler
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Collegium Q4 2025 slides: ADHD drug surges despite earnings miss
Le BPA de Collegium Pharmaceutical a manqué les attentes de 0,10$, le CA en dessous des prévisions
Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates
Résultats de Collegium Pharmaceutical : focus sur Jornay PM
Collegium Pharmaceutical earnings ahead: Jornay PM in focus
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?
Collegium Pharmaceutical to Report Q4 Earnings: What's in the Cards?
Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates
Truist Securities raises Collegium Pharmaceutical stock price target to $58
Collegium Pharmaceutical Stock: Buying The Projected Growth For 2026 (NASDAQ:COLL)
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?